Europe, Middle East & Africa
Insights guided by expertise.
Identify opportunity, maximize potential
Successfully maximize results for your portfolio and build your business for the longer term. From global views to local studies, IQVIA’s unparalleled breadth and depth of data combined with advanced analytics supports your business intelligence at every level.
- Assess your own and competitor market size, share and growth dynamics across drugs, diseases and countries
- Find the most promising areas to focus investments and grow your business
- Refine your business model to manage the requirements of a specific country or region
- Review the profitability of legacy brands, and where they are headed, today and tomorrow
- Understand therapies most likely to gain approval in an increasingly demanding payer environment
- Prepare for the impact of loss of protection on your markets
- Predict the effect of competitor launches on your therapy areas
- Identify key dynamics of a therapy or disease area
- Make effective decisions with robust global deals intelligence
80,000 deals
tracked since 199610,000 drugs
covered in quarterly analytics and forecasts across 600 diseases and 70+ countries28K+ HTA records
helping inform payer decisions4,200 price records
including treatments at each available pack size and strength across the EU-5 and the USMachine learning brings new insights to light
What sets IQVIA analytics and insights apart isn’t only the depth of our data. It’s the power of our algorithms to uncover precisely the type of information that’s most valuable to your business goals. By using statistical analysis to identify patterns and predict outcomes, we can help you
-
Understand disease dynamics: See the key medicines used in treating specific conditions and the predicted impact of future launches on an indication
-
Find the right doctors: Uncover high-potential healthcare providers for your drug, and recommend when and how to contact them
-
Demonstrate value to payers: Develop customized market insights backed by more than 26,000 Health Technology Assessment records and more than 4,200 pricing records
